XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
REVENUE    
Revenue $ 1,396,898 $ 222,557
OPERATING EXPENSES    
Cost of revenue (exclusive of amortization shown separately below) 1,261,487 3,029
Sales and marketing 694,486 52,746
Product development 17,984 11,937
Amortization of intangibles 272,315 314,410
General and administrative 3,926,896 893,740
Total operating expenses 6,173,168 1,275,862
LOSS FROM OPERATIONS (4,776,270) (1,053,305)
OTHER INCOME (EXPENSES)    
Interest expense (37,834) (365,853)
Gain on assets sale 0 100,000
Gain (loss) on change in fair value of marketable securities 1,809 (108,512)
Gain on debt extinguishment, net 0 579,977
Other income 0 5,170
Change in fair value of derivative liability 113,333 0
Change in fair value of contingent consideration 164,384 0
Change in fair value of warrant liability (7,585) 64,096
Total other income, net 234,107 274,878
Loss before income taxes (4,542,163) (778,427)
Provision for income taxes 0 0
NET LOSS (4,542,163) (778,427)
Net income attributable to noncontrolling interests (16,595) 0
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (4,558,758) $ (778,427)
NET LOSS PER COMMON SHARE - BASIC $ (0.30) $ (0.40)
NET LOSS PER COMMON SHARE - DILUTED $ (0.30) $ (0.40)
Weighted average common shares outstanding - basic 15,412,809 1,947,492
Weighted average common shares outstanding - diluted 15,412,809 1,947,492